VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.
The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.
A majority 62% of the poll respondents said that the delays are very likely, while 19% opined that the delays are ‘somewhat likely’.
Delays are unlikely, according to just 19% of the respondents.
The analysis is based on 679 responses received during the poll period from 26 March to 02 April.
The coronavirus outbreak is also expected to cause clinical trial delays, according to another poll run by Verdict during the same period.
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Preclinical Development Services for the Pharmaceutical Industry
Contract Manufacturing Organisation and Pharmaceutical Supply Services